Bolt Biotherapeutics, Inc. ( BOLT) - Key Metrics
BOLT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $1.13 | -$3.72 | -$5.07 | -$5.11 |
| 2025Q2 | $0.94 | -$4.46 | -$5 | -$5 |
| 2025Q1 | $0.03 | -$0.29 | -$0.35 | -$0.35 |
BOLT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -0.36 |
| 2025Q2 | ? | -0.32 |
| 2025Q1 | ? | -6.95 |
BOLT
Price: $3.99
52 week price:
Earnings Per Share: -17.85 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 121100
Market Capitalization: 9.1 million